Načítá se...
MicroRNAs in pancreatic cancer diagnosis and therapy
Pancreatic cancer remains a disease with very poor prognosis (only 5-6% of patients are still alive after five years). Attempts to improve the results of treatment of pancreatic cancer focus on a better understanding of the pathogenesis, and non-invasive diagnostic methods (genetic testing from peri...
Uloženo v:
| Vydáno v: | Cent Eur J Immunol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Polish Society of Experimental and Clinical Immunology
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6305615/ https://ncbi.nlm.nih.gov/pubmed/30588176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceji.2018.80051 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|